Valuation: EBOS Group Limited

Market Cap 3.22B 2.23B 1.98B 1.85B 1.69B 3.18B 215B 22.42B 8.68B 109B 8.38B 8.2B 351B P/E 2027 *
13.8x
P/E 2028 * 12.2x
Enterprise Value 4.24B 2.93B 2.61B 2.44B 2.22B 4.18B 282B 29.47B 11.41B 144B 11.01B 10.77B 462B EV / Sales 2027 *
0.3x
EV / Sales 2028 * 0.29x
Free-Float
90.79%
Yield 2027 *
6.09%
Yield 2028 * 6.6%
1 day+3.15%
1 month-10.38%
3 months-10.38%
6 months-38.18%
Current year-33.49%
1 month 22.59
Extreme 22.5885
26.61
Current year 22.59
Extreme 22.5885
46.64
1 year 22.59
Extreme 22.5885
46.64
3 years 22.59
Extreme 22.5885
47.23
5 years 22.59
Extreme 22.5885
47.23
10 years 22.59
Extreme 22.5885
47.23
Manager TitleAgeSince
Chief Executive Officer 51 30/06/2025
Director of Finance/CFO - 29/09/2024
Chief Tech/Sci/R&D Officer - 04/08/2024
Director TitleAgeSince
Chairman 66 -
Director/Board Member - 30/06/2019
Director/Board Member 60 30/06/2021
Change 5-day change 1-year change 3-year change Capi.($)
+3.15%-.--% - - 2.27B
-0.62%-2.71%+39.30%+114.07% 1,031B
-2.30%-4.44%+39.03%+66.07% 638B
-0.63%-1.96%+6.36%+74.38% 462B
-1.03%-2.82%+59.56%+39.69% 359B
-0.03%-3.96%+23.63%+39.35% 335B
-1.58%-0.76%+13.50%+25.77% 273B
-2.02%-2.97%-3.25%+8.38% 253B
-3.38%+0.30%+36.44%+51.54% 228B
-1.04%-1.46%+32.70%+96.82% 185B
Average -0.95%-1.58%+27.47%+57.34% 418.21B
Weighted average by Cap. -1.25%-1.89%+30.52%+69.18%

Financials

2027 *2028 *
Net sales 14.03B 9.71B 8.63B 8.07B 7.35B 13.84B 935B 97.61B 37.79B 476B 36.47B 35.68B 1,530B 14.66B 10.15B 9.01B 8.43B 7.68B 14.46B 977B 102B 39.47B 498B 38.09B 37.27B 1,598B
Net income 229M 159M 141M 132M 120M 226M 15.29B 1.6B 618M 7.79B 596M 583M 25.01B 261M 181M 161M 150M 137M 258M 17.4B 1.82B 703M 8.86B 679M 664M 28.47B
Net Debt 1.01B 702M 623M 583M 531M 1B 67.55B 7.05B 2.73B 34.4B 2.63B 2.58B 111B 975M 675M 599M 560M 511M 961M 64.96B 6.78B 2.62B 33.08B 2.53B 2.48B 106B
Logo EBOS Group Limited
EBOS Group Limited is a marketer, wholesaler and distributor of healthcare, medical and pharmaceutical products. The Company is also the owner, product marketer and distributor of animal care brands. Its segments include Healthcare, Animal Care, and Corporate. The Healthcare segment includes sales of healthcare products in a range of sectors, through its own brands, retail healthcare, pharmacy, hospital and logistic services, and wholesale activities. The Animal Care segment includes sales of animal care products in a range of sectors, own manufactured and contract manufactured brands, retail, and wholesale activities. Its Community Pharmacy business includes Symbion, ProPharma, Pharmacy Wholesalers Russells, TerryWhite Chemmart, Good Price Pharmacy Warehouse, healthSAVE, Ventura Health, Minfos, DoseAid, Intellipharm, Endeavour Consumer Health, and Red Seal. Its contract logistics include Healthcare Logistics, Healthcare Logistics Clinical Trials and Clinect.
Employees
5,364
Date Price Change Volume
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
15.57AUD
Average target price
23.27AUD
Spread / Average Target
+49.38%

Quarterly revenue - Rate of surprise